Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/bph.15157

http://scihub22266oqcxt.onion/10.1111/bph.15157
suck pdf from google scholar
32519753!7300643!32519753
unlimited free pdf from europmc32519753    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32519753      Br+J+Pharmacol 2020 ; 177 (21): 4967-4970
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The potential of cannabidiol in the COVID-19 pandemic #MMPMID32519753
  • Esposito G; Pesce M; Seguella L; Sanseverino W; Lu J; Corpetti C; Sarnelli G
  • Br J Pharmacol 2020[Nov]; 177 (21): 4967-4970 PMID32519753show ga
  • Identifying drugs effective in the new coronavirus disease 2019 (COVID-19) is crucial, pending a vaccine against SARS-CoV2. We suggest the hypothesis that cannabidiol (CBD), a non-psychotropic phytocannabinoid, has the potential to limit the severity and progression of the disease for several reasons:- (a) High-cannabidiol Cannabis sativa extracts are able to down-regulate the expression of the two key receptors for SARS-CoV2 in several models of human epithelia, (b) cannabidiol exerts a wide range of immunomodulatory and anti-inflammatory effects and it can mitigate the uncontrolled cytokine production responsible for acute lung injury, (c) being a PPARgamma agonist, it can display a direct antiviral activity and (d) PPARgamma agonists are regulators of fibroblast/myofibroblast activation and can inhibit the development of pulmonary fibrosis, thus ameliorating lung function in recovered patients. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test cannabidiol as a support drug against the COVID-19 pandemic. LINKED ARTICLES: This article is part of a themed issue on The Pharmacology of COVID-19. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.21/issuetoc.
  • |Animals[MESH]
  • |Betacoronavirus/drug effects/isolation & purification[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Cannabidiol/*administration & dosage/isolation & purification/pharmacology[MESH]
  • |Cannabis/chemistry[MESH]
  • |Coronavirus Infections/*drug therapy/virology[MESH]
  • |Disease Progression[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]
  • |Plant Extracts/chemistry/pharmacology[MESH]
  • |Pneumonia, Viral/*drug therapy/virology[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box